Alvotech (ALVO) Other Non Operating Income (2021 - 2026)
Alvotech's (ALVO) quarterly Other Non Operating Income came in at $2.4 million in Q2 2026, up 120.22% on a YoY basis from $1.1 million in Q2 2025, and up 283.55% quarter-over-quarter from -$1.3 million in Q1 2026.
Analysis
Alvotech (ALVO) Other Non Operating Income (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Other Non Operating Income for 6 consecutive years, with $2.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non Operating Income rose 120.22% year-over-year to $2.4 million; the trailing twelve-month figure through Jun 2026 stood at -$20.1 million (up 87.88% YoY), and the FY2025 full-year result was -$16.8 million, up 75.73% from the prior year.
- Other Non Operating Income rose to $2.4 million in Q2 2026 per ALVO's latest filing, from -$1.3 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $32.1 million in Q2 2022 and bottomed at -$77.1 million in Q3 2024.
- Historically, Other Non Operating Income has averaged -$11.7 million across 5 years, with a median of -$4.1 million in 2023.
- The widest YoY moves for Other Non Operating Income: up 226.03% in 2024, down 1238.57% in 2024.
- Over 5 years, Other Non Operating Income stood at -$27.3 million in 2022, then surged by 81.02% to -$5.2 million in 2023, then slumped by 1238.57% to -$69.4 million in 2024, then jumped by 71.63% to -$19.7 million in 2025, then surged by 112.08% to $2.4 million in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $2.4 million, -$1.3 million, and -$19.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.56 Bn | 38.90 Bn | 2.15 Bn |
| 2 | Viatris | 19.17 Bn | 18.28 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.88 Bn | 9.71 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.47 Bn | 5.35 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.35 Bn | 507.63 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 996.39 Mn | 706.27 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 401.41 Mn | 360.16 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.38 Mn |
| Mar 31, 2026 | -1.30 Mn |
| Dec 31, 2025 | -19.68 Mn |
| Sep 30, 2025 | -1.54 Mn |
| Jun 30, 2025 | -11.75 Mn |
| Mar 31, 2025 | -7.93 Mn |
| Dec 31, 2024 | -69.38 Mn |
| Sep 30, 2024 | -77.12 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 6.53 Mn |
| Dec 31, 2023 | -5.18 Mn |
| Aug 31, 2023 | -3.08 Mn |
| Jun 30, 2023 | -1.33 Mn |
| Mar 20, 2023 | -5.18 Mn |
| Dec 31, 2022 | -27.31 Mn |
| Aug 31, 2022 | 4.74 Mn |
| Jun 30, 2022 | 32.06 Mn |
| Mar 20, 2022 | -27.31 Mn |
| Dec 31, 2021 | 149.23 Mn |